CD19 and lymphoproliferative syndrome: We also calculated the proportion and number of CD5+ CD19+ B cells (also known as B1 cells) as this subset is associated with various autoimmune and lymphoproliferative disorders [23], and was shown to be expanded in a cohort of HCV patients [24].